malondialdehyde has been researched along with Cystic Fibrosis in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 10 (38.46) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Charvat, J; Fila, L; Havlin, J; Hloch, O; Palova, S | 1 |
| Antus, B; Barta, I; Drozdovszky, O; Kelemen, K | 1 |
| Ansarin, K; Jouyban, A; Khoubnasabjafari, M | 1 |
| Antus, B; Barta, I | 1 |
| Assael, BM; Bambara, LM; Biondani, A; Bortolami, O; Carta, F; D'Orazio, C; De Franceschi, L; Faccini, G; Guarini, P; La Verde, V; Pattini, P; Poli, F; Scambi, C; Siciliano, A; Turrini, F | 1 |
| Bieszczad-Bedrejczuk, E; Pawliszak, K; Pazdan, J; Rachel, M; Sadowska-Woda, I | 1 |
| Biasi, F; Bignamini, E; Calabrese, R; Lezo, A; Massarenti, P; Poli, G; Santini, B | 1 |
| Lloyd-Still, JD | 1 |
| Bérubé, D; Bureau, N; Champagne, J; Chemtob, S; Lepage, G; Ronco, N; Roy, CC; Yesair, DW | 1 |
| Chełchowska, M; Laskowska-Klita, T; Narolewska, U; Nowaczewska, I | 1 |
| Abbas-Chorfa, F; Bellon, G; Drai, J; Durieu, I; Ecochard, R; Lagrange-Puget, M; Pacheco, Y; Steghens, JP; Vital-Durand, D | 1 |
| Kapranov, NI; Kashirskaia, NIu; Pukhal'skiĭ, AL; Shmarina, GV | 1 |
| Dawczynski, H; Jahreis, G; Janitzky, E; Kauf, E; Winnefeld, K | 1 |
| Esterbauer, H; Khoschsorur, G; Puhl, H; Shmerling, DH; van't Hof, MA; Winklhofer-Roob, BM | 1 |
| Brown, RK; Kelly, FJ | 1 |
| Champagne, J; Lamarre, A; Lepage, G; Osberg, I; Ronco, N; Roy, CC; Sokol, RJ | 1 |
| Winklhofer-Roob, BM | 1 |
| Ellemunter, H; Frühwirth, M; Khoschsorur, G; Schlegel-Haueter, SE; Shmerling, DH; van't Hof, MA; Winklhofer-Roob, BM | 1 |
| Eichler, I; Elmadfa, I; Renner, S; Rust, P | 1 |
| Cobos, N; Domínguez, C; Gartner, S; Liñán, S; Moreno, A | 1 |
| Eichler, I; Elmadfa, I; Frischer, T; Lehr, S; Rath, R; Renner, S; Rust, P | 1 |
| Biró, L; Greiner, E; Holics, K; Lugassi, A; Madarasi, A; Mozsáry, E | 1 |
| Kalashnikova, EA; Kapranov, NI; Kashirskaja, NJ; Kokarovtseva, SN; Pukhalskaya, DA; Pukhalsky, AL; Shmarina, GV | 1 |
| Coudray, C; Favier, A; Hadjian, A; Meo, J; Portal, B; Richard, MJ | 1 |
| Aguilaniu, B; Arnaud, J; Favier, A; Gout, JP; Richard, MJ | 1 |
| Cynamon, HA; Isenberg, JN | 1 |
8 trial(s) available for malondialdehyde and Cystic Fibrosis
| Article | Year |
|---|---|
Preliminary evidence for cell membrane amelioration in children with cystic fibrosis by 5-MTHF and vitamin B12 supplementation: a single arm trial.
Topics: Antiporters; Cations; Child; Child, Preschool; Cystic Fibrosis; Dietary Supplements; Erythrocyte Membrane; Erythrocytes; Female; Homocysteine; HSP70 Heat-Shock Proteins; Humans; Ion Transport; Male; Malondialdehyde; Membrane Fluidity; Membrane Lipids; Oxidative Stress; Phospholipids; Tetrahydrofolates; Vitamin B 12 | 2009 |
Nutritional supplement attenuates selected oxidative stress markers in pediatric patients with cystic fibrosis.
Topics: Adolescent; Antioxidants; Biomarkers; Child; Child, Preschool; Cystic Fibrosis; Dietary Supplements; Dosage Forms; Erythrocytes; Humans; Male; Malondialdehyde; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase; Vitamins | 2011 |
Effect of an organized lipid matrix on lipid absorption and clinical outcomes in patients with cystic fibrosis.
Topics: Adolescent; Adult; Anthropometry; Area Under Curve; beta Carotene; Canada; Child; Child Welfare; Cystic Fibrosis; Dietary Fats; Diterpenes; Double-Blind Method; Eicosanoids; Energy Intake; Fatty Acids; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Intestinal Absorption; Liver; Male; Malondialdehyde; Patient Compliance; Retinol-Binding Proteins; Retinyl Esters; Time Factors; Treatment Outcome; Triglycerides; Vitamin A; Vitamins | 2002 |
Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis.
Topics: beta Carotene; Carotenoids; Child; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Cystic Fibrosis; Female; Humans; Lipid Peroxidation; Lipid Peroxides; Lipoproteins, LDL; Male; Malondialdehyde; Oxidation-Reduction; Reference Values; Regression Analysis; Vitamin E | 1995 |
Evidence for increased oxidative damage in patients with cystic fibrosis.
Topics: Adolescent; Adult; Ascorbic Acid; Biomarkers; Blood Proteins; Child; Child, Preschool; Cystic Fibrosis; Fatty Acids, Nonesterified; Female; Humans; Lipid Peroxides; Male; Malondialdehyde; Oxidative Stress; Reference Values; Thiobarbituric Acid Reactive Substances; Vitamin E | 1994 |
Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis.
Topics: Adolescent; Adult; beta Carotene; Carotenoids; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Lipid Peroxidation; Male; Malondialdehyde; Vitamin E | 1996 |
Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis.
Topics: Adolescent; Antioxidants; Ascorbic Acid; beta Carotene; Carotenoids; Child; Cystic Fibrosis; Humans; Lipid Peroxidation; Lycopene; Malondialdehyde; Vitamin A; Vitamin E | 1998 |
Effects of beta-carotene supplementation for six months on clinical and laboratory parameters in patients with cystic fibrosis.
Topics: Adolescent; Adult; Antioxidants; beta Carotene; Child; Cystic Fibrosis; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Lipid Peroxidation; Male; Malondialdehyde; Treatment Outcome; Vital Capacity | 2001 |
18 other study(ies) available for malondialdehyde and Cystic Fibrosis
| Article | Year |
|---|---|
Significance of plasma fibrinogen and malondialdehyde in the post-inflammatory period in patients with cystic fibrosis.
Topics: Adult; C-Reactive Protein; Cystic Fibrosis; Fibrinogen; Humans; Malondialdehyde; Plasma | 2022 |
Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis.
Topics: Adult; Area Under Curve; Breath Tests; Case-Control Studies; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Malondialdehyde; Neutrophils; Nitric Oxide; Oxidative Stress; Pseudomonas aeruginosa; Pseudomonas Infections; Reproducibility of Results; ROC Curve; Sputum; Young Adult | 2015 |
Comments Concerning "Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis".
Topics: Cystic Fibrosis; Female; Humans; Male; Malondialdehyde; Oxidative Stress; Sputum | 2015 |
Response to the Letter Entitled "Comments Concerning Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis".
Topics: Cystic Fibrosis; Female; Humans; Male; Malondialdehyde; Oxidative Stress; Sputum | 2015 |
Oxidative stress in stable cystic fibrosis patients: do we need higher antioxidant plasma levels?
Topics: Aldehydes; Biomarkers; Child; Child, Preschool; Cysteine Proteinase Inhibitors; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Fluorometry; Humans; Infant; Male; Malondialdehyde; Oxidative Stress; Reference Values | 2013 |
Essential fatty acid deficiency and nutritional supplementation in cystic fibrosis.
Topics: beta Carotene; Cystic Fibrosis; Dietary Fats; Dietary Supplements; Diterpenes; Eicosanoids; Energy Intake; Fatty Acids, Essential; Forced Expiratory Volume; Humans; Intestinal Absorption; Malondialdehyde; Retinol-Binding Proteins; Retinyl Esters; Triglycerides; Vitamin A; Vitamins | 2002 |
[Markers of oxidative damage in blood of children with cystic fibrosis].
Topics: Biomarkers; Blood Proteins; Child; Cystic Fibrosis; Diet Therapy; Exocrine Pancreatic Insufficiency; Female; Humans; Lipid Peroxides; Male; Malondialdehyde; Oxidative Stress; Poland; Risk Factors | 2002 |
Longitudinal study of oxidative status in 312 cystic fibrosis patients in stable state and during bronchial exacerbation.
Topics: Adolescent; Adult; Antioxidants; Biomarkers; Case-Control Studies; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Lipid Peroxidation; Lipid Peroxides; Longitudinal Studies; Male; Malondialdehyde; Middle Aged; Oxidation-Reduction; Oxidative Stress; Probability; Prognosis; Prospective Studies; Reference Values; Regression Analysis; Respiratory Function Tests; Risk Assessment; Severity of Illness Index; Vitamin E Deficiency | 2004 |
[Dynamics of markers of blood inflammation against the background of antibacterial therapy in children with mucoviscidosis, with the various regimens of intake of pancreatic enzymes].
Topics: Adolescent; Anti-Bacterial Agents; Biomarkers; Child; Cystic Fibrosis; Enzyme Therapy; Female; Humans; Inflammation; Inflammation Mediators; Lymphocyte Activation; Lymphocytes; Male; Malondialdehyde; Oxidative Stress; Pancreas; Pseudomonas aeruginosa; Pseudomonas Infections; Sputum | 2004 |
Sodium selenite therapy and thyroid-hormone status in cystic fibrosis and congenital hypothyroidism.
Topics: Adolescent; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Congenital Hypothyroidism; Cystic Fibrosis; Female; Humans; Hypothyroidism; Male; Malondialdehyde; Selenium; Sodium Selenite; Thyroid Hormones; Thyroxine; Triiodothyronine; Vitamin E; Vitamin E Deficiency | 1994 |
beta-Carotene, malondialdehyde, and cystic fibrosis.
Topics: Antioxidants; beta Carotene; Cystic Fibrosis; Humans; Malondialdehyde | 1997 |
Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation.
Topics: Adolescent; Adult; Ascorbic Acid; beta Carotene; Child; Child, Preschool; Cohort Studies; Cystic Fibrosis; Cytokines; Dose-Response Relationship, Drug; Female; Humans; Infant; Inflammation; Interleukin-6; Leukocyte Elastase; Lipid Peroxidation; Lung Diseases; Male; Malondialdehyde; Nutritional Status; Orosomucoid; Seasons; Tumor Necrosis Factor-alpha; Vitamin E | 1997 |
Enhanced oxidative damage in cystic fibrosis patients.
Topics: Adolescent; Adult; Antioxidants; Child; Child, Preschool; Cystic Fibrosis; Female; Glutathione Reductase; Humans; Infant; Lipid Peroxides; Male; Malondialdehyde; Reference Values; Superoxide Dismutase; Vitamin E | 1998 |
Antioxidant status in patients with cystic fibrosis.
Topics: Antioxidants; Ascorbic Acid; Catalase; Child; Cystic Fibrosis; Female; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Malondialdehyde; Nutritional Status; Superoxide Dismutase; Vitamin A; Vitamin E | 2000 |
Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients.
Topics: Absorption; Adolescent; Child; Cystic Fibrosis; Female; Humans; Lymphocyte Activation; Male; Malondialdehyde; Nutrition Disorders; Oxidative Stress | 2001 |
Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid.
Topics: Adolescent; Adult; Antioxidants; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cystic Fibrosis; Female; Humans; Lipid Peroxidation; Lipoproteins; Male; Malondialdehyde; Quality Control; Reagent Kits, Diagnostic; Reference Values; Thiobarbiturates | 1992 |
Selenium and oxidant injury in patients with cystic fibrosis.
Topics: Adolescent; Adult; Antioxidants; Child; Child, Preschool; Cystic Fibrosis; Erythrocytes; Glutathione Peroxidase; Humans; Infant; Lipid Peroxidation; Malondialdehyde; Metalloproteins; Nutrition Disorders; Nutritional Physiological Phenomena; Selenium; Trace Elements | 1990 |
Application of a new test for vitamin E deficiency to cystic fibrosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Cystic Fibrosis; Erythrocytes; Humans; Infant; Malonates; Malondialdehyde; Vitamin E; Vitamin E Deficiency | 1987 |